KineMed, Inc. Release: Novel Atherosclerosis-Reversing, Heart Disease Therapy Wins National Institutes of Health (NIH) Clinical Development Grant

Published: Apr 10, 2012

EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed Inc. ( today announced its successful award of a Rapid Access to Intervention Development (RAID) peer-reviewed grant by the National Institute of Health to advance an HDL mimetic, designated FX-5A, designed to reverse atherosclerosis and heart disease.

Back to news